Proctor and Gamble 2004 Annual Report Download - page 25
Download and view the complete annual report
Please find page 25 of the 2004 Proctor and Gamble annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.FiscalYear2004Results
TheHealthCarebusinessunitdelivereditsfifthconsecutive
yearofstrongdouble-digitgrowthinvolume,salesand
profit.Volumeincreased18%,salesgrew21%andnet
earningsincreased36%behindoutstandingnewproduct
innovationsandimprovingprofitmargins.
AlloftheHealthCarebusinesssegmentsdeliveredgreat
resultsinfiscal2004.Actonelledthegrowthin
Pharmaceuticals,buildingglobalvalueshareinthefast-
growingosteoporosistreatmentcategorytobecome
abillion-dollarbrand.PersonalHealthCaregrowthwas
fueledbythelaunchofPrilosecOTCforthetreatment
offrequentheartburn.PrilosecOTCiswidelyregarded
asoneofthemostsuccessfulover-the-counterhealthcare
launchesever.TheCrestbrandbecametheclearOral
CaremarketleaderintheU.S.CrestWhiteningExpressions
andVividWhitedroveshareintheU.S.toothpaste
segmenttoover33%,andCrestWhitestripsPremium
droveU.S.toothwhiteningsharetoover70%.Iams
continuedtodeliversteadygrowth,postingitsfifth
consecutiveyearofU.S.marketshareincreases.Iamsis
nowthe#1petnutritionbrandintheU.S.
HealthCare
What’sWorking
P&G’sHealthCarebusinesscontinuestobedrivenbya
powerfulcombinationofbreakthroughinnovation,strategic
acquisitionsandalliances,andoperatingcostdiscipline.
Inthelastfouryearsalone,newhealthcareinnovations
havecontributedmorethan$1.5billioninincrementalsales.
ThisgrowthcomesfromastrictapplicationofP&G’s
“launchandleverage”approach.
First,HealthCaredevelopsandlaunchesoutstandingnew
productswithholisticintroductorymarketingplansand
excellentin-storeexecution.PrilosecOTCisanexcellent
exampleofP&G’sinitiativelaunchcapabilities.
Second,weleveragethesenewproductswithstrong
marketingsupportandproductimprovementsforseveral
yearsafterinitiallaunch.Twogreatexamplesofthis“launch
andleverage”approachareCrestWhitestripsandActonel,
whichhavecontinuedtodeliverstrongsalesgrowthin
theirthirdandfourthyearsinthemarket,respectively.
TheacquisitionofCrestSpinBrushin2001andGlideFloss
lastyearhavehelpedmakeP&Galeadingplayerinallmajor
segmentsoftheoralcaremarket.Upstreamdevelopment
allianceswithpharmaceuticalcompanieshavehelpedus
developafullpipelineoflife-enhancingdrugsthatareat
variousstagesoftesting.Andwhileweinvesttosupport
newproductlaunchesandresearchtodeveloptomorrow’s
breakthroughnewproducts,weareintightcontrolof
operatingcosts.Onlywithstrictcostcontrolcanwedeliver
newproductsatagreatvalueforconsumerswhilestill
deliveringanexcellentreturnforourshareholders.
Iams
Iamslatestdogandcatnutrition
innovationdeliversasignificanttaste
improvementforbetterfeeding
andincludessevennutrientsfor
healthyhearts.
PrilosecOTC
PrilosecOTCbecametheleading
over-the-counterheartburnremedy
intheU.S.withinfivedaysoflaunch.
Firstyearretailsalesareexpected
toapproach$400million.
Actonel
Infiscalyear2004,Actonelbecame
P&G’sthirdHealthCarebrandto
reach$1billioninglobalsales.
Actonelreachedthebillion-dollar
milestoneinjustfouryearsbased
onglobalalliancesales.
Crest
Crestworldwidesalesgrewmore
than13%infiscalyear2004,
behindnewinnovationslikeCrest
WhitestripsPremium,CrestVivid
WhiteandCrestWhitening
Expressions.
23
NetSales
(inbillionsofdollars)
NetEarnings
(inmillionsofdollars)